Q-linea AB (publ) announced that the company has signed an evaluation contract with a large network reference laboratory headquartered in the United States. With the announcement of FDA clearance of the ASTar System and a Gram-negative panel (ASTar BC G-Consumable Kit), Q- linea has already signed a contract under the Early Evaluation Program with a large network reference laboratory and is in active conversations with several hospital systems for the same.